9/13/2022 5:03:09 PM
DaVita Appoints Adam Schechter To Its Board Of Directors
8/1/2022 4:18:47 PM
DaVita Q2 EPS $2.30 Vs. $2.64 Year Ago
5/26/2022 6:46:23 AM
Medtronic And DaVita Intent To Form Independent Kidney Care-focused Medical Device Company
5/5/2022 4:12:13 PM
DaVita Q1 EPS $1.61 Vs. $2.09 Year Ago
3/1/2022 6:27:05 AM
Pathalys Pharma Acquires License To EA Pharma's Upacicalcet Worldwide Outside Of Japan And Asia
2/17/2022 6:07:02 AM
DaVita Clinical Research Study Finds Efficacy Of Common COVID-19 Vaccines At Parity For Kidney Patients
2/16/2022 6:04:59 AM
DaVita Kidney Care Appoints Mihran Naljayan As Chief Medical Officer (CMO) Of Home Modalities
2/10/2022 4:07:40 PM
DaVita Q4 EPS $1.79 Vs. $1.5 0 Year Ago
1/18/2022 6:09:36 AM
DaVita Announces Acquisition Of MedSleuth
12/16/2021 6:05:44 AM
DaVita Integrated Kidney Care Names David Roer Chief Medical Officer
12/9/2021 6:03:55 AM
DaVita Says Its North American Operations Powered By 100% Renewable Energy
10/28/2021 4:13:25 PM
DaVita Q3 EPS $2.36 Vs. $1.28 Year Ago
10/11/2021 6:03:30 AM
DaVita Climate Action Goals Approved By Science Based Target Initiative